Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 125 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Συντάκτης is Tsolaki, Magda  [Clear All Filters]
2011
Thambisetty, M., Simmons A., Hye A., Campbell J., Westman E., Zhang Y., et al. (2011).  Plasma biomarkers of brain atrophy in Alzheimer's disease.. PLoS One. 6(12), e28527.
Westman, E., Cavallin L., Muehlboeck J-S., Zhang Y., Mecocci P., Vellas B., et al. (2011).  Sensitivity and specificity of medial temporal lobe visual ratings and multivariate regional MRI classification in Alzheimer's disease.. PLoS One. 6(7), e22506.
Bamidis, P. D., Konstantinidis E. I., Billis A., Frantzidis C., Tsolaki M., Hlauschek W., et al. (2011).  A Web services-based exergaming platform for senior citizens: the Long Lasting Memories project approach to e-health care.. Conf Proc IEEE Eng Med Biol Soc. 2011, 2505-9.
2010
Liu, Y., Paajanen T., Zhang Y., Westman E., Wahlund L-O., Simmons A., et al. (2010).  Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease.. Neurobiol Aging. 31(8), 1375-85.
Liu, Y., Paajanen T., Westman E., Zhang Y., Wahlund L-O., Simmons A., et al. (2010).  APOE ε2 allele is associated with larger regional cortical thicknesses and volumes.. Dement Geriatr Cogn Disord. 30(3), 229-37.
Thambisetty, M., Simmons A., Velayudhan L., Hye A., Campbell J., Zhang Y., et al. (2010).  Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease.. Arch Gen Psychiatry. 67(7), 739-48.
Paajanen, T., Hänninen T., Tunnard C., Mecocci P., Sobow T., Tsolaki M., et al. (2010).  CERAD neuropsychological battery total score in multinational mild cognitive impairment and control populations: the AddNeuroMed study.. J Alzheimers Dis. 22(4), 1089-97.
Papaliagkas, V. T., Tsolaki M., & Anogianakis G. (2010).  Cerebrospinal fluid proteins in the diagnosis of Alzheimer's disease.. Recent Pat CNS Drug Discov. 5(2), 172-8.
Tsolaki, M., Messini C. Z., Siapera M., Fotiadou F., Delaporta D., & Karatolias A. (2010).  Depression, extrapyramidal symptoms, dementia and an unexpected outcome: a case report.. Cases J. 3, 47.
Emre, M., Bernabei R., Blesa R., Bullock R., Cunha L., Daniëls H., et al. (2010).  Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer disease.. CNS Neurosci Ther. 16(4), 246-53.
Liu, Y., Paajanen T., Westman E., Wahlund L-O., Simmons A., Tunnard C., et al. (2010).  Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study.. J Alzheimers Dis. 21(3), 947-66.
Emre, M., Tsolaki M., Bonuccelli U., Destée A., Tolosa E., Kutzelnigg A., et al. (2010).  Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial.. Lancet Neurol. 9(10), 969-77.
Tsolaki, M., Papaliagkas V., Kounti F., Messini C., Boziki M., Anogianakis G., et al. (2010).  Severely stressful events and dementia: a study of an elderly Greek demented population.. Psychiatry Res. 176(1), 51-4.
2009
Lovestone, S., Francis P., Kloszewska I., Mecocci P., Simmons A., Soininen H., et al. (2009).  AddNeuroMed--the European collaboration for the discovery of novel biomarkers for Alzheimer's disease.. Ann N Y Acad Sci. 1180, 36-46.
Tsolaki, M., Eleftheriou M., & Karavida N. (2009).  Alzheimer's dementia and post-traumatic stress disorder differences and similarities in neuroimaging.. Hell J Nucl Med. 12(1), 41-6.
Tsolaki, M., Paraskevi S., Degleris N., & Karamavrou S. (2009).  Attitudes and perceptions regarding Alzheimer's disease in Greece.. Am J Alzheimers Dis Other Demen. 24(1), 21-6.
Mattsson, N., Zetterberg H., Hansson O., Andreasen N., Parnetti L., Jonsson M., et al. (2009).  CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.. JAMA. 302(4), 385-93.
Kountouras, J., Boziki M., Gavalas E., Zavos C., Grigoriadis N., Deretzi G., et al. (2009).  Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer's disease.. J Neurol. 256(5), 758-67.
Harold, D., Abraham R., Hollingworth P., Sims R., Gerrish A., Hamshere M. L., et al. (2009).  Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.. Nat Genet. 41(10), 1088-93.
Kountouras, J., Boziki M., Gavalas E., Zavos C., Deretzi G., Grigoriadis N., et al. (2009).  Increased cerebrospinal fluid Helicobacter pylori antibody in Alzheimer's disease.. Int J Neurosci. 119(6), 765-77.
Froelich, L., Andreasen N., Tsolaki M., Foucher A., Kavanagh S., Van Baelen B., et al. (2009).  Long-term treatment of patients with Alzheimer's disease in primary and secondary care: results from an international survey.. Curr Med Res Opin. 25(12), 3059-68.
Simmons, A., Westman E., Muehlboeck S., Mecocci P., Vellas B., Tsolaki M., et al. (2009).  MRI measures of Alzheimer's disease and the AddNeuroMed study.. Ann N Y Acad Sci. 1180, 47-55.
Visser, P. Jelle, Verhey F., Knol D. L., Scheltens P., Wahlund L-O., Freund-Levi Y., et al. (2009).  Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.. Lancet Neurol. 8(7), 619-27.
Birks, J., Evans J. Grimley, Iakovidou V., Tsolaki M., & Holt F. E. (2009).  Rivastigmine for Alzheimer's disease.. Cochrane Database Syst Rev. CD001191.
Tsolaki, M., Kounti F., & Karamavrou S. (2009).  Severe psychological stress in elderly individuals: a proposed model of neurodegeneration and its implications.. Am J Alzheimers Dis Other Demen. 24(2), 85-94.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές